Price $2.26 |
Market Cap
54M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
5.4
|
P/S
-
|
Dividend %
-
|
|
P/CF
5.3
|
P/FCF
-
|
Op. Cash Flow
-20.1K
|
FCF
-0.9
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-
|
ROI
-
|
|
ROA
-694.80%
|
EPS Growth
23.70%
|
Current Ratio
4.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Clearside Biomedical Inc (CLSD) | $1.08 | - | - | 99.2M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.40 | - | - | 152.2M | Strong Buy |
| Harrow Health Inc (HROW) | $7.61 | - | - | 180.6M | Strong Buy |
| Stoke Therapeutics Inc (STOK) | $13.03 | - | - | 603.1M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $0.84 | - | - | 41M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
